These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 26636047)

  • 1. Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis.
    Josse J; Velard F; Gangloff SC
    Front Cell Infect Microbiol; 2015; 5():85. PubMed ID: 26636047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus isolates from chronic osteomyelitis are characterized by high host cell invasion and intracellular adaptation, but still induce inflammation.
    Kalinka J; Hachmeister M; Geraci J; Sordelli D; Hansen U; Niemann S; Oetermann S; Peters G; Löffler B; Tuchscherr L
    Int J Med Microbiol; 2014 Nov; 304(8):1038-49. PubMed ID: 25129555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro.
    Sanchez CJ; Ward CL; Romano DR; Hurtgen BJ; Hardy SK; Woodbury RL; Trevino AV; Rathbone CR; Wenke JC
    BMC Musculoskelet Disord; 2013 Jun; 14():187. PubMed ID: 23767824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sarA and Phenol-Soluble Modulins on the Pathogenesis of Osteomyelitis in Diverse Clinical Isolates of Staphylococcus aureus.
    Loughran AJ; Gaddy D; Beenken KE; Meeker DG; Morello R; Zhao H; Byrum SD; Tackett AJ; Cassat JE; Smeltzer MS
    Infect Immun; 2016 Sep; 84(9):2586-94. PubMed ID: 27354444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Maturation of Human Primary Bone-Forming Cells on Their Behavior in Acute or Persistent Staphylococcus aureus Infection Models.
    Josse J; Guillaume C; Bour C; Lemaire F; Mongaret C; Draux F; Velard F; Gangloff SC
    Front Cell Infect Microbiol; 2016; 6():64. PubMed ID: 27446812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.
    Mohamed W; Domann E; Chakraborty T; Mannala G; Lips KS; Heiss C; Schnettler R; Alt V
    BMC Microbiol; 2016 Oct; 16(1):230. PubMed ID: 27716055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of TNFR1 Suppresses Expression of TLR2 in the Cellular Response to Staphylococcus aureus Infection.
    Chen Q; Hou T; Wu X; Luo F; Xie Z; Xu J
    Inflammation; 2016 Apr; 39(2):798-806. PubMed ID: 26846887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis.
    Ellington JK; Harris M; Hudson MC; Vishin S; Webb LX; Sherertz R
    J Orthop Res; 2006 Jan; 24(1):87-93. PubMed ID: 16419973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of staphylococci with osteoblasts and phagocytes in the pathogenesis of implant-associated osteomyelitis.
    Arciola CR; Hänsch GM; Visai L; Testoni F; Maurer S; Campoccia D; Selan L; Montanaro L
    Int J Artif Organs; 2012 Oct; 35(10):713-26. PubMed ID: 23080215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis.
    Ellington JK; Harris M; Webb L; Smith B; Smith T; Tan K; Hudson M
    J Bone Joint Surg Br; 2003 Aug; 85(6):918-21. PubMed ID: 12931819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis.
    Hendrix AS; Spoonmore TJ; Wilde AD; Putnam NE; Hammer ND; Snyder DJ; Guelcher SA; Skaar EP; Cassat JE
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5322-30. PubMed ID: 27324764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.
    Muthukrishnan G; Masters EA; Daiss JL; Schwarz EM
    Curr Osteoporos Rep; 2019 Dec; 17(6):395-404. PubMed ID: 31721069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.
    Dusane DH; Kyrouac D; Petersen I; Bushrow L; Calhoun JH; Granger JF; Phieffer LS; Stoodley P
    J Orthop Res; 2018 Apr; 36(4):1086-1092. PubMed ID: 28885721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interactions of Streptococcus gordonii and Staphylococcus aureus with cultured osteoblasts.
    Jauregui CE; Mansell JP; Jepson MA; Jenkinson HF
    Mol Oral Microbiol; 2013 Aug; 28(4):250-66. PubMed ID: 23413785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.
    Tuchscherr L; Kreis CA; Hoerr V; Flint L; Hachmeister M; Geraci J; Bremer-Streck S; Kiehntopf M; Medina E; Kribus M; Raschke M; Pletz M; Peters G; Löffler B
    J Antimicrob Chemother; 2016 Feb; 71(2):438-48. PubMed ID: 26589581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual impact of live Staphylococcus aureus on the osteoclast lineage, leading to increased bone resorption.
    Trouillet-Assant S; Gallet M; Nauroy P; Rasigade JP; Flammier S; Parroche P; Marvel J; Ferry T; Vandenesch F; Jurdic P; Laurent F
    J Infect Dis; 2015 Feb; 211(4):571-81. PubMed ID: 25006047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis.
    Widaa A; Claro T; Foster TJ; O'Brien FJ; Kerrigan SW
    PLoS One; 2012; 7(7):e40586. PubMed ID: 22792377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR/FAK and c-Src signalling pathways mediate the internalisation of Staphylococcus aureus by osteoblasts.
    Ji Z; Su J; Hou Y; Yao Z; Yu B; Zhang X
    Cell Microbiol; 2020 Oct; 22(10):e13240. PubMed ID: 32584493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratiopeptidase reduces the invasion of osteoblasts by Staphylococcus aureus.
    Selan L; Papa R; Ermocida A; Cellini A; Ettorre E; Vrenna G; Campoccia D; Montanaro L; Arciola CR; Artini M
    Int J Immunopathol Pharmacol; 2017 Dec; 30(4):423-428. PubMed ID: 29212390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis.
    Campbell MJ; Bustamante-Gomez C; Fu Q; Beenken KE; Reyes-Pardo H; Smeltzer MS; O'Brien CA
    Bone; 2024 Oct; 187():117181. PubMed ID: 38960295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.